Exogene

Exogene is a VC-backed biotechnology startup using deep learning to unlock the discovery of innovative cell therapies for cancer treatment. We are building a deep learning platform to rapidly identify specialised molecules that can guide immune cells within cancer patients to destroy cancer cells. The platform is trained on massive proprietary wet-lab datasets we generate in-house. Our mission is to discover cell therapies for untreatable solid tumours using a hybrid wet-lab/computational approach. We are a remote-first company with labs at the BioEscalator in Oxford, UK.